| | | | | | | | | Sponsored | | We understand what’s at stake–timely detection of transplant-associated viral targets can be critical. Our transplant-focused ASR§ portfolio is designed to support the needs of mid-volume molecular labs to develop their own LDTs without compromising flexibility or workflow efficiency. See our full menu of ASRs§ available for BK virus, CMV, EBV, HHV-6, 7 & 8, JCV, and VZV. |
|
|
| | |
| |
| | |
|
|
| | | | | | On May 12, the College of American Pathologists hosted a media briefing on hantavirus in response to the outbreak of the Andes strain of the virus on the luxury cruise ship MV Hondius. |
|
|
| | The life sciences industry faces significant skills shortages due to aging workforces, complex niche roles, and rapid technological advancements. This article addresses how to help bridge these gaps, fostering a more competent and adaptable workforce ready for future challenges. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Healthcare providers face increasing pressure to make flawless clinical decisions, often with fragmented data and cognitive overload. Join Dr. Ari Frenkel, infectious disease physician and Chief Science Officer at Arkstone, on May 28 for a live webinar on how AI-powered clinical decision support is transforming the speed and quality of decision-making in infectious disease, when minutes matter most. |
|
|
| | |
| |
| | |
|
|
| | | | | | What do healthcare professionals need to know about health system operating margins? In this article, originally published by our sister publication, Healthcare Innovation, Theresa Houck provides an overview of what hospitals and health systems are currently facing. |
|
|
|
| |
| | |
|
|
| | | | | | Need P.A.C.E. credit? Our May CE explains that the laboratory of the future is not simply automated—it is intelligent, continuously learning from its own data and monitoring its systems, where technology strengthens rather than replaces professional judgment. |
|
|
|
| |
| | |
|
|
| | | | | | The cell culture media market is projected to grow at a CAGR of 10.8%, reaching USD 10.8 billion by 2035, fueled by rising chronic diseases, biologics demand, and technological advances in media formulations. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
